Quisovalimab clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses quisovalimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2017 (1)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Avalo Therapeutics, Inc. (2) · Aevi Genomic Medicine, LLC, a Cerecor company (1)
Studies
Open first, then newest update. How each study uses quisovalimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.CompletedPhase 2Avalo Therapeutics, Inc.NCT05288504Written as AVTX-002
- Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative ColitisTerminatedPhase 1Avalo Therapeutics, Inc.NCT03169894Written as MDGN-002
- Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung InjuryCompletedPhase 2Aevi Genomic Medicine, LLC, a Cerecor companyNCT04412057Written as CERC-002
Codes
What other systems call quisovalimab · ClinicalTrials.gg INT017239
- UNII (FDA) M46KZB8QXLQUISOVALIMABOne source FDA
- NCI Thesaurus C184870QuisovalimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | M46KZB8QXL | QUISOVALIMAB | One source FDA |
| NCI Thesaurus | C184870 | Quisovalimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.